1. Home
  2. RPD vs FTRE Comparison

RPD vs FTRE Comparison

Compare RPD & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPD
  • FTRE
  • Stock Information
  • Founded
  • RPD 2000
  • FTRE 1996
  • Country
  • RPD United States
  • FTRE United States
  • Employees
  • RPD N/A
  • FTRE N/A
  • Industry
  • RPD Computer Software: Prepackaged Software
  • FTRE Medical Specialities
  • Sector
  • RPD Technology
  • FTRE Health Care
  • Exchange
  • RPD Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • RPD 881.4M
  • FTRE 864.4M
  • IPO Year
  • RPD 2015
  • FTRE N/A
  • Fundamental
  • Price
  • RPD $15.67
  • FTRE $13.02
  • Analyst Decision
  • RPD Hold
  • FTRE Hold
  • Analyst Count
  • RPD 21
  • FTRE 8
  • Target Price
  • RPD $24.00
  • FTRE $11.64
  • AVG Volume (30 Days)
  • RPD 1.4M
  • FTRE 1.4M
  • Earning Date
  • RPD 11-04-2025
  • FTRE 11-05-2025
  • Dividend Yield
  • RPD N/A
  • FTRE N/A
  • EPS Growth
  • RPD N/A
  • FTRE N/A
  • EPS
  • RPD 0.35
  • FTRE N/A
  • Revenue
  • RPD $858,667,000.00
  • FTRE $2,759,900,000.00
  • Revenue This Year
  • RPD $2.75
  • FTRE $0.47
  • Revenue Next Year
  • RPD $3.21
  • FTRE N/A
  • P/E Ratio
  • RPD $44.56
  • FTRE N/A
  • Revenue Growth
  • RPD 3.08
  • FTRE 1.88
  • 52 Week Low
  • RPD $13.21
  • FTRE $3.97
  • 52 Week High
  • RPD $44.47
  • FTRE $25.05
  • Technical
  • Relative Strength Index (RSI)
  • RPD 50.29
  • FTRE 66.15
  • Support Level
  • RPD $13.41
  • FTRE $9.87
  • Resistance Level
  • RPD $14.00
  • FTRE $13.37
  • Average True Range (ATR)
  • RPD 0.50
  • FTRE 0.94
  • MACD
  • RPD 0.27
  • FTRE 0.21
  • Stochastic Oscillator
  • RPD 83.85
  • FTRE 89.92

About RPD Rapid7 Inc.

Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: